Company intelligence / Profile preview
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Ganzhou, Jiangxi, Chinaen.yangsen.com.cn ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
The company has several approved products in China and the United States, including XiYanPing (approved March 25, 2025 in China), Citrus aurantium total flavonoid tablets (approved October 19, 2023 in China), and Bupivacaine Hydrochloride/Lidocaine Hydrochloride (approved May 23, 2003 in the United States). They also have products in Phase 3 clinical trials, including Danlong Zhiyang Capsule and a Rabies Vaccine.
- Therapeutic areas
- PulmonologyOtherDermatologyGastroenterologyInfectious Diseases
- Modalities
- Small molecule drugsHerbal medicineProphylactic vaccines
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Partnerships
GinkgoPharma (for GP681)Beijing Cell-fusion Biotechnology Co. Ltd. (for Rabies Vaccine)
Beyond the preview
Go deeper on Jiangxi Qingfeng Pharmaceutical Co. Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangxi Qingfeng Pharmaceutical Co. Ltd..